Search

everythinglearnresearchcommunity

for

Search:↓

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Nano-quercetin improves quercetin's effectiveness in treating diseases but faces challenges in safety and production.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

A new ethical skin model using stem cells offers a reliable alternative for dermatological research.

Micro-segmental hair analysis helps detect drug use patterns and estimate drug consumption days.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Finasteride safely lowers DHT levels without affecting testosterone.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Finasteride effectively treats male hair loss, improving growth and density.

First-episode psychosis patients have higher hair cortisol levels, indicating early stress response issues.

Turmeric essential oil compounds have potential as safe, effective drugs.

Cubosomes enhance antimicrobial peptide stability and effectiveness.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

Wnt1a helps keep cells that can grow hair effective for potential hair loss treatments.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Improving drug delivery through the skin requires understanding skin and using enhancers.

Finasteride affects young male rats' brain function and behavior negatively.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Platelet-rich plasma can temporarily inhibit some drug-resistant bacteria in diabetic foot infections.

The document discusses a condition causing hair loss after surgery and a type of rosacea affecting the nose, with treatments including surgery and laser therapy.

Researchers created a mouse cell line to study hair growth and test hair growth drugs.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

SLE in Iraqi patients often involves hair loss and photosensitivity, with common treatments being corticosteroids and immunosuppressants.

Chitosan is useful in skin treatments because it helps with wound healing and cell growth.

Scientists developed tools to observe hair regeneration in real time and assess skin health, using glowing mice and light-controlled genes.

Testosterone reduces, while finasteride enhances, morphine's pain relief.